Oragen to present ONP-002 intranasal platform at IPAC-RS 2026
Oragen said its CMO will present clinical translation of ONP-002 and intranasal delivery progress at IPAC-RS 2026. The company also said it plans an IND submission and Phase IIa progress.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.